StockNews.AI
TKNO
StockNews.AI
180 days

Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

1. TKNO to report Q4 and full year 2024 financial results. Earnings announcement expected to impact stock movements. 2. Conference call and webcast set for March 4, 2025 after market close. Registration is required. 3. Company emphasizes its leadership in producing life sciences reagents. Innovation in reagent manufacturing remains a focus.

Earnings
-6.76%Current Return
VS
-1.72%S&P 500
$7.9902/20 04:18 PM EDTEvent Start
$7.4502/21 10:34 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Neutral?

This earnings announcement is a routine, scheduled event. Historically, similar releases cause short-term volatility without long-term directional shifts if results meet expectations.

How important is it?

While earnings results may prompt short-term price fluctuations, the announcement itself is routine and lacks unexpected catalysts.

Why Short Term?

Earnings reports typically drive immediate investor reactions that dissipate shortly. Past events have shown short-lived price movements after routine earnings announcements.

Related Companies

TMO
February 20, 2025 16:05 ET  | Source: Alpha Teknova, Inc. HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2024, on Tuesday, March 4, 2025, following the close of market. Teknova will host a webcast and conference call on Tuesday, March 4, 2025, beginning at 5 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this link. If you would like to participate in the call, please register for the webcast here to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event. About TeknovaTeknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in molecular diagnostics, synthetic biology, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies. Investor ContactMatt LowellChief Financial Officermatt.lowell@teknova.com+1 831-637-1100  Media ContactJennifer HenrySenior Vice President, Marketingjenn.henry@teknova.com+1 831-313-1259

Related News